The agreement also grants Top Care Korea exclusive rights to distribute Exalenz’s BreathID System in Korea. Top Care Korea plans to launch BreathID System in first half of 2008.
Hyun Mo Chung, CEO of Top Care Korea, said: “Together with Exalenz, we will provide a powerful set of diagnostic tools for patients with gastrointestinal and liver disease. We believe this agreement will immediately strengthen our competitive position.”